HOME >> BIOLOGY >> NEWS
Human-Like Ability, Categorical Perception, Found In Insects

biologists set up a cricket flight chamber, wired for sound, computerized data-gathering and a built-in breeze from a fan, to make the cricket think it is flying while tethered in midair. "We weren't looking for the so-called continuous perception," Wyttenbach said, explaining that continuous perception allows human color vision to discriminate hundreds of variations between "blue" and "green," even though humans cannot precisely label each bluish-sort-of-green color.

"A more useful ability in some situations is our ability to tell the difference between sounds like 'ba' and 'pa,' " Wyttenbach noted. "Even though there is a continuum of variation between 'ba' and 'pa' based on voice onset time or VOT, which instruments can detect, our ears don't discriminate. We hear either 'ba' or 'pa' and that's how we label it. That is categorical perception, and it looked like crickets might categorically perceive sounds as either 'other crickets' or 'bats.' "

Categorical perception previously had been shown at other laboratories in monkeys, chinchillas and some species of birds, Wyttenbach knew, but getting crickets to explain how they make up their minds would be tricky. His flight chamber experiments were showing that playback sounds mimicking cricket calls made the tethered insects "fly" toward the speaker. And sounds in the bat's ultrasound range made the crickets veer away from the speaker. Still, he couldn't very well ask the crickets: "Do 20 kHz and 40 kHz sound the same or different?"

So the neurobiologists turned to a test suggested by Cornell Professor of Psychology Elizabeth Spelke for another category of notoriously uncooperative research subjects, human babies. Spelke's habituation-dishabituation test determines precisely what stimulus level is "different enough" to get a subject's attention when it has grown accustomed to (or habituated to ) repeated stimuli. Babies respond less and less when they hear "pa" repeated over and over; they pay a
'"/>

Contact: Roger Segelken
hrs2@cornell.edu
607-255-9736
Cornell University News Service
13-Sep-1996


Page: 1 2 3

Related biology news :

1. Brown ecologist garners major National Science Foundation grant
2. APS Foundation names student travel award recipients
3. Institute for OneWorld Health receives Gates Foundation grant
4. National Parkinson Foundation designates UNC as Center of Excellence
5. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
6. Betty Ann Forbes wins 2004 ASM Founders Award
7. Leslie Ann Schiff wins 2004 Carski Foundation Award
8. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
9. National Foundation For Cancer Research names UCSDs Webster Cavenee NFCR Fellow
10. Founder of UCSD bioengineering program honored with lifetime achievement award
11. Green Foundation, Trust gives $12.8 million for UT Southwestern comprehensive research center

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Human Like Ability Categorical Perception Found Insects

(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: